Acarix AB Stock Nasdaq Stockholm
Equities
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- SEK | - |
06-11 | Acarix Announces Enrollment of First Patient in Us-Based Clinical Workflow Evaluation Study | CI |
05-27 | Acarix AB Appoints Jeff Thomas as the New Head of US Sales, Effective June 1, 2024 | CI |
Sales 2024 * | 54.3M 5.13M 7.02M | Sales 2025 * | 177M 16.69M 22.84M | Capitalization | 358M 33.84M 46.31M |
---|---|---|---|---|---|
Net income 2024 * | -54M -5.1M -6.98M | Net income 2025 * | 2M 189K 259K | EV / Sales 2024 * | 6.52 x |
Net cash position 2024 * | 4M 378K 517K | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 2.03 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 81.96% |
Latest transcript on Acarix AB
Managers | Title | Age | Since |
---|---|---|---|
Founder | 60 | 06-12-31 | |
Director of Finance/CFO | 60 | 15-12-31 | |
Jennifer Matson
CTO | Chief Tech/Sci/R&D Officer | 47 | 21-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 51 | 21-05-10 | |
Director/Board Member | 59 | 19-12-31 |
1st Jan change | Capi. | |
---|---|---|
-34.90% | 14.88B | |
-54.48% | 2.26B | |
+19.59% | 1.89B | |
-8.65% | 1.52B | |
+19.52% | 1.19B | |
-24.23% | 871M | |
+2.14% | 781M | |
-34.22% | 750M | |
-29.20% | 591M |